Project ECHO^®: Cardiovascular Toxicities
with Immune Checkpoint Inhibitors

Telementoring To Manage Immune-related Adverse Events
in Patients Receiving Cancer Immunotherapies

Session 1 — Cardiology

CME Information or Content Source:

Content Derived from a CME Certified Webinar in September 2022
Event Sponsor(s):

This activity is supported by an educational grant from Bristol Myers Squibb.
Event Details:

Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)

Date Recorded:

September 20, 2022
Recording Length:

49:06
Topics:

ACCC, Boston University, cardiovascular, immunotherapy, irAE, Project ECHO

Speakers

Avirup Guha, MD, MBBS, MPH, FACC, FICOS, RPVI
Director of Cardio-Oncology, Cardio-Oncology Program, Georgia Cancer Center
Assistant Professor of Medicine, Division of Cardiovascular Disease, Augusta University
An expert in cardiovascular epidemiology pertaining to cardio-oncology

Laura Wood, RN, MSN OCN
Oncology Nurse Specialist, Medina, Ohio

Learning Objectives

At the end of this educational program, participants should be able to:

Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Click here to learn about remaining Project ECHO sessions or to view other available recordings.